newsfilter
← Latest News
GlobeNewswire·

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

Reiterating timelines for FDA submission in 2025Transplant clinical trial has attracted leading transplant hospitalsBooked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second